Successful treatment of onychomycosis with ciclopirox nail lacquer: a case report.

Abstract

Onychomycosis commonly causes patients to seek medical care. Its unpleasant cosmetic appearance and negative impact on a patient's quality of life often prompt these visits. Onychomycosis rarely resolves spontaneously and has a high rate of recurrence. Although a variety of treatment options are available, inconsistent results and poor patient compliance have often hindered their success. We report the case of a 75-year-old man with moderate-to-severe onychomycosis who was treated successfully with ciclopirox nail lacquer solution 8%, the first topical antifungal agent approved by the Food and Drug Administration for the treatment of this disease.

• Authors: J Galitz
• Journal: Cutis (Cutis) Vol. 68 Issue 2 Suppl Pg. 23-4 (Aug 2001) ISSN: 0011-4162 [Print] United States
• PMID: 11665725 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antifungal Agents
• Pyridones
• Ciclopirox

Topics

• Administration, Topical
• Aged
• Antifungal Agents (administration & dosage, therapeutic use)
• Ciclopirox
• Foot Dermatoses (drug therapy)
• Humans
• Male
• Onychomycosis (drug therapy)
• Pyridones (administration & dosage, therapeutic use)